IQ MacKay Shields Municipal Intermediate ETF MMIT 深 沪
已收盘 12-31 16:00:00 美东时间
24.33
+0.017
+0.07%
华盛通- 最 高24.34
- 今 开24.33
- 成交量 24.67万股
- 最 低 24.30
- 昨 收 24.313
- 总市值 8.70亿
- 52周最高 24.3664
- 市盈率 静 --
- 换手率 0.69%
- 52周最低 22.3414
- 委 比 -56.33%
- 总股本 3575.00万
- 历史最高 24.34
- 量 比 0.78
- 振 幅 0.16%
- 历史最低 17.8587
- 每 手 1
- 风险率 0.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mobius Investment Trust to Publish November 2025 Monthly Factsheet
An announcement from Mobius Investment Trust Plc ( ($GB:MMIT) ) is now availabl...
2025-12-19 18:47
New York Life Bets On Long-Duration Munis As Tax-Free Yields Heat Up
New York Life launches the MMMA ETF, an actively managed municipal bond ETF targeting higher tax-free income as long-term muni yields sit near decade highs.
2025-12-17 03:10
Reported Saturday, Cogent Biosciences Highlights Bezuclastinib Rapid, Deep, Sustained Improvement In Objective Measures Of Mast Cell Burden In SUMMIT NonAdvSM Study
Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual symptoms plus the most severe symptom at baseline --Bezuclastinib demonstrates that
2025-12-08 17:06
台达参加2025 CDCC SUMMIT中国数据中心标准大会
11月20日-21日，全球电源管理与散热解决方案的重要厂商台达，以SST固态变压器、800V直流供电架构、数据中心液冷等AI算力中心的核心技术为支撑，在202...
2025-11-25 17:47
华大电子参加ITMA SUMMIT 2025
11月18日，ITMA SUMMIT 2025于深圳召开。华大电子副总经理陈波涛应邀出席并发表主题演讲《NFC技术演进深度剖析——开启智能交互新纪元》，系统阐述...
2025-11-20 17:19
SUMMIT HOTEL PROPERTIES PUBLISHES 2025 CORPORATE RESPONSIBILITY REPORT
AUSTIN, Texas, Nov. 11, 2025 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced the publication of its annual Corporate Responsibility Report, which re...
2025-11-12 05:30
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2025 DIVIDENDS
AUSTIN, Texas, Oct. 31, 2025 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declar...
2025-11-01 05:00
Cogent gains FDA Breakthrough Therapy status for bezuclastinib
The US FDA has granted Breakthrough Therapy designation for Cogent Biosciences' bezuclastinib for NonAdvanced Systemic Mastocytosis and Smoldering Systemic Mastocytosis. The company plans an NDA submi...
2025-10-21 05:21
Mobius Investment Trust Director Acquires Shares
Mobius Investment Trust Plc ( ($GB:MMIT) ) has shared an announcement. Mobius I...
2025-09-29 20:57
MAJOR TECH GIANTS IBM, SAP, MITSUBISHI ELECTRIC UNITE TO HOST UNPRECEDENTED 24-HOUR INNERSOURCE SUMMIT
Historic gathering reveals how open collaborative development practices enable ...
2025-09-25 04:33
